Overview
Thomas Van Gelder practices practicing medicine in Utrecht, Netherlands.
His clinical expertise encompasses Neurotoxicity Syndromes and Post-Traumatic Stress Disorder (PTSD).
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Thomas G. Van Gelder
Is Thomas G. Van Gelder a top-rated expert for Neurotoxicity Syndromes?
MediFind is an objective health platform that identifies experts based on real-world data. Thomas G. Van Gelder is classified as an Experienced expert for Neurotoxicity Syndromes, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Thomas G. Van Gelder participate in research or clinical trials?
Yes. Thomas G. Van Gelder has published 8 articles and abstracts on conditions like Neurotoxicity Syndromes. You can view a list of Thomas G. Van Gelder's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Neurotoxicity SyndromesMr. Van Gelder isExperienced. Learn about Neurotoxicity Syndromes.
- Post-Traumatic Stress Disorder (PTSD)Mr. Van Gelder isExperienced. Learn about Post-Traumatic Stress Disorder (PTSD).